Canada markets closed

Can-Fite BioPharma Ltd. (CANF)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
1.9700+0.0250 (+1.29%)
At close: 03:59PM EDT
2.0600 +0.09 (+4.57%)
After hours: 05:41PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 11.94M
Enterprise Value 7.27M
Trailing P/E N/A
Forward P/E 2.89
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)15.63
Price/Book (mrq)4.84
Enterprise Value/Revenue 10.89
Enterprise Value/EBITDA 0.10

Trading Information

Stock Price History

Beta (5Y Monthly) 0.61
52-Week Change 3-8.80%
S&P500 52-Week Change 332.65%
52 Week High 34.6900
52 Week Low 31.8100
50-Day Moving Average 32.4034
200-Day Moving Average 32.3630

Share Statistics

Avg Vol (3 month) 3111.38k
Avg Vol (10 day) 3134.64k
Shares Outstanding 56.1M
Implied Shares Outstanding 64.08M
Float 81.67B
% Held by Insiders 10.00%
% Held by Institutions 19.80%
Shares Short (Sept 13, 2024) 4202.21k
Short Ratio (Sept 13, 2024) 42.56
Short % of Float (Sept 13, 2024) 43.72%
Short % of Shares Outstanding (Sept 13, 2024) 43.32%
Shares Short (prior month Aug 15, 2024) 4175.73k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3May 10, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Jan 09, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,295.57%

Management Effectiveness

Return on Assets (ttm)-57.46%
Return on Equity (ttm)-157.62%

Income Statement

Revenue (ttm)667k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-19.40%
Gross Profit (ttm)N/A
EBITDA -7.79M
Net Income Avi to Common (ttm)-7.37M
Diluted EPS (ttm)-2.6000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.73M
Total Cash Per Share (mrq)0
Total Debt (mrq)57k
Total Debt/Equity (mrq)2.30%
Current Ratio (mrq)2.93
Book Value Per Share (mrq)0.00

Cash Flow Statement

Operating Cash Flow (ttm)-7.43M
Levered Free Cash Flow (ttm)-4.55M